Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nanus

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Cancer Cell|March 5, 2004
Aminopeptidase A is a functional target in angiogenic blood vesselsSerena Marchiò, Johanna Lahdenranta, Reinier O Schlingemann, et al.
Frontiers in Oncology|February 6, 2024
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysisMajd Al Assaad, Nara Shin, Michael Sigouros, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progressionSilvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
JCO Precision Oncology|November 6, 2020
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate CancerAndrew J Armstrong, Jun Luo, David M Nanus, et al.
Science Translational Medicine|March 22, 2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancerLoredana Puca, Katie Gavyert, Verena Sailer, et al.
NPJ Precision Oncology|March 29, 2025
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancerJones T Nauseef, Timothy R Chu, William F Hooper, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
Nature Communications|December 4, 2020
Common germline-somatic variant interactions in advanced urothelial cancerAram Vosoughi, Tuo Zhang, Kyrillus S Shohdy, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Cancer Cell|March 5, 2004
Aminopeptidase A is a functional target in angiogenic blood vesselsSerena Marchiò, Johanna Lahdenranta, Reinier O Schlingemann, et al.
Frontiers in Oncology|February 6, 2024
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysisMajd Al Assaad, Nara Shin, Michael Sigouros, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progressionSilvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
JCO Precision Oncology|November 6, 2020
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate CancerAndrew J Armstrong, Jun Luo, David M Nanus, et al.
Science Translational Medicine|March 22, 2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancerLoredana Puca, Katie Gavyert, Verena Sailer, et al.
NPJ Precision Oncology|March 29, 2025
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancerJones T Nauseef, Timothy R Chu, William F Hooper, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
Nature Communications|December 4, 2020
Common germline-somatic variant interactions in advanced urothelial cancerAram Vosoughi, Tuo Zhang, Kyrillus S Shohdy, et al.
Pageof 17